Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Incident and Accident Reporting and Investigation – V 2.0

Posted on By

API Manufacturing: SOP for Incident and Accident Reporting and Investigation – V 2.0

Standard Operating Procedure for Incident and Accident Reporting and Investigation in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/206/2025
Supersedes SOP/API/206/2022
Page No. Page 1 of 13
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a structured process for immediate reporting, thorough investigation, and effective resolution of all workplace incidents and accidents in API manufacturing, including near misses. This SOP ensures compliance with EHS standards, promotes employee safety, and drives continuous improvement through root cause analysis and preventive actions.

2. Scope

This SOP applies to all incidents

and accidents occurring in API production, warehouses, laboratories, maintenance areas, and administrative zones, including chemical exposures, equipment malfunctions, injuries, near misses, and environmental incidents.

3. Responsibilities

  • Employees: Promptly report all incidents or unsafe conditions to supervisors.
  • Supervisors: Initiate first-level documentation and notify the EHS team.
  • EHS Officer: Lead formal investigation, conduct root cause analysis, and recommend CAPA.
  • QA Representative: Verify procedural compliance and maintain documentation.
  • HR Department: Coordinate medical attention, if required, and handle insurance-related processes.
See also  API Manufacturing: SOP for Review of Validation Protocols and Reports - V 2.0

4. Accountability

The Head of EHS is accountable for the implementation and effectiveness of the incident and accident management system, including corrective and preventive actions, closure timelines, and communication to stakeholders.

5. Procedure

5.1 Definitions

  • Incident: Any unplanned event that does not result in injury but has the potential to do so (near miss).
  • Accident: An unplanned event that causes injury, illness, or property/environmental damage.

5.2 Immediate Reporting

  1. Any person witnessing or involved in an incident/accident must inform their supervisor immediately.
  2. Initial details to be noted in the Incident Reporting Log (Annexure-1).
  3. Serious injuries must be reported to EHS, QA, and plant management within 30 minutes.

5.3 First Response and Containment

  1. Secure the area and prevent access to others.
  2. Provide first aid or medical attention as necessary.
  3. Isolate energy sources if equipment is involved (lock-out/tag-out).
  4. Take photographs and gather evidence before cleanup (where safe).

5.4 Formal Investigation

  1. EHS shall form an investigation team for moderate to major incidents.
  2. Use the Incident/Accident Investigation Form (Annexure-2) for:
    • Sequence of events
    • Personnel involved
    • Witness statements
    • Root cause analysis (5-Why/Fishbone)

5.5 Classification of Severity

  1. Incidents shall be classified as:
    • Level 1: Minor incident – no injury or loss
    • Level 2: Moderate – first aid injury/property damage < ₹10,000
    • Level 3: Major – hospitalization, regulatory reportable, fire, or environmental damage
  2. Level 3 incidents must be reported to local authorities as per the Factories Act.
See also  API Manufacturing: SOP for Water Analysis by KF Titration - V 2.0

5.6 Corrective and Preventive Action (CAPA)

  1. Investigators shall define CAPAs based on root causes.
  2. Each CAPA must be assigned to a responsible person with target dates.
  3. Track CAPAs in the Incident CAPA Tracker (Annexure-3).

5.7 Closure and Review

  1. Close incident only after CAPA completion and verification by EHS and QA.
  2. Record final closure in the Incident Closure Log (Annexure-4).
  3. Serious incidents to be reviewed during monthly EHS Committee meetings (Annexure-5).

5.8 Training and Communication

  1. Lessons learned shall be communicated via toolbox talks and bulletin boards.
  2. Annual refresher training shall include real-life case discussions.

6. Abbreviations

  • EHS: Environment, Health & Safety
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • PPE: Personal Protective Equipment
  • SOP: Standard Operating Procedure

7. Documents

  1. Incident Reporting Log – Annexure-1
  2. Incident/Accident Investigation Form – Annexure-2
  3. Incident CAPA Tracker – Annexure-3
  4. Incident Closure Log – Annexure-4
  5. EHS Committee Meeting Record – Annexure-5

See also  API Manufacturing: SOP for Investigation of Out-of-Trend (OOT) Results - V 2.0

8. References

  • Factories Act, 1948 – Sections on Safety and Health
  • OSHA 1904 – Recording and Reporting Occupational Injuries and Illnesses
  • ICH Q10 – Pharmaceutical Quality System
  • ISO 45001 – Occupational Health and Safety Management System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Incident Reporting Log

Date Location Type Reported By Initial Action
13/04/2025 Solvent Area Near Miss Sunita Reddy Area Isolated

Annexure-2: Incident/Accident Investigation Form

Incident ID Type Description Root Cause Investigator
INC-024 Accident Slip on wet floor No caution signage Rajesh Kumar

Annexure-3: Incident CAPA Tracker

CAPA ID Action Owner Status Due Date
CAPA-024 Install caution boards Maintenance Completed 15/04/2025

Annexure-4: Incident Closure Log

Incident ID Date Closed By QA Verified Remarks
INC-024 15/04/2025 EHS Officer Yes Closed

Annexure-5: EHS Committee Meeting Record

Date Chairperson Key Topics Decisions
01/04/2025 Plant Head Review of Incidents Install additional safety posters

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
14/04/2025 2.0 Updated classification and annexures Regulatory Update QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Gel Manufacturing: SOP for Sampling of Packaged Gels for QC – V 2.0
Next Post: Analytical Method Development: SOP for Analytical Method for Creams and Gels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version